Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers

Por Welters, Alena, Lerch, Christian, Kummer, Sebastian, Marquard, Jan, Salgin, Burak, Mayatepek, Ertan, Meissner, Thomas
Publicado no Orphanet J Rare Dis (2015)

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review

Por Farsani, Soulmaz Fazeli, Brodovicz, Kimberly, Soleymanlou, Nima, Marquard, Jan, Wissinger, Erika, Maiese, Brett A
Publicado no BMJ Open (2017)

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial

Por Shimada, Akira, Hanafusa, Toshiaki, Yasui, Atsutaka, Lee, Ganghyuck, Taneda, Yusuke, Sarashina, Akiko, Shiki, Kosuke, George, Jyothis, Soleymanlou, Nima, Marquard, Jan
Publicado no Diabetes Obes Metab (2018)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes

Por Bjornstad, Petter, Laffel, Lori, Tamborlane, William V., Simons, Gudrun, Hantel, Stefan, von Eynatten, Maximilian, George, Jyothis, Marquard, Jan, Cherney, David Z.I.
Publicado no Diabetes Care (2018)

NMDA receptor dependent anti-diabetic effects

Por Marquard, Jan, Otter, Silke, Welters, Alena, Herebian, Diran, Demir, Fatih, Schroeter, Annett, Kletke, Olaf, Kragl, Martin, Eberhard, Daniel, Bartosinska, Barbara, Klemen, Masa Skelin, Stozer, Andraz, Köhler, Martin, Stirban, Alin, Schliess, Freimut, Heise, Tim, Wnendt, Stephan, Rupnik, Marjan Slak, Berggren, Per-Olof, Klöcker, Nikolaj, Meissner, Thomas, Mayatepek, Ertan, Lammert, Eckhard
Publicado no Mol Cell Pediatr (2014)